-
Experimental Drug Shows Signs of Slowing Cognitive Decline in Alzheimer's Patients, Study Finds
New data shows an experimental Alzheimer’s drug modestly slowed the brain disease’s inevitable worsening. The next question is how much difference that might make in people’s lives.
-
Medicare Weighs Premium Cut After Limiting Alzheimer's Drug
Medicare says it’s considering a cut in enrollee premiums, after officials stuck with an earlier decision to sharply limit coverage for a pricey new Alzheimer’s drug projected to drive up program costs
-
Medicare Limits Coverage of $28,000-A-Year Alzheimer's Drug
Medicare says it will limit coverage of a $28,000-a-year Alzheimer’s drug whose benefits have been widely questioned
-
Medicare Told to Reassess Premium Hike for Alzheimer's Drug
U.S. health secretary Xavier Becerra is ordering Medicare to reassess a big premium increase facing millions of seniors this year
-
Why Biogen's Alzheimer's Drug Aduhelm Is So Controversial
Biogen’s Alzheimer’s drug Aduhelm was heralded as a historic triumph against the memory-robbing disease. Now, the company is trying to keep it afloat.
-
WATCH: Maine Trooper Carries Missing Elderly Man Out of Ditch
A Maine state trooper has come to the aid of an elderly man with Alzheimer’s disease who had wandered away from his home during a storm and ended up in a ditch. Troopers got their missing person report from a home in Vassalboro at about 5 a.m. Wednesday. They also received information from a town plow truck driver that...
-
Waiting to Talk Finance With an Aging Parent in Cognitive Decline Is a Mistake, Experts Say
Waiting to talk to an aging parent about their financial future until they experience cognitive decline is a mistake, say financial advisors.
-
Financial Scam Serves as Warning for Those Seeking a Caregiver for Older Relatives
Billions of dollars are stolen from seniors each year. Financial fraud and exploitation is the most prevalent form of elder abuse.
-
Researchers Have High Hopes for Alzheimer's Vaccine
A clinical trial for a nasal vaccine for Alzheimer’s will soon be underway at Brigham and Women’s Hospital.
-
Brigham and Women's to Begin Clinical Trial for Nasal Alzheimer's Vaccine
Brigham and Women’s Hospital is launching the first human clinical trial for a nasal vaccine for Alzheimer’s disease.
-
Woman Convinced Husband He Had Alzheimer's, Then Stole $600K: PD
A Connecticut woman was arrested Wednesday, accused of stealing $600,000 from her husband by convincing him he had Alzheimer’s disease in order to hide it from him, police said.
-
In Quiet Debut, Alzheimer's Drug Finds Questions, Skepticism
Persistent concerns about the first new Alzheimer’s treatment in more than 20 years are curbing access more than four months after regulators approved it.
-
A Harvard Nutritionist and Brain Expert Shares the 5 Foods She Eats Every Day to Sharpen Her Memory and Focus
A daily diet of colorful fruits and vegetables can help make your brain strong, sharper and smarter, studies show. Here’s what a Harvard nutritional psychiatrist eats to strengthen her memory, focus and overall health.
-
Insurers Debate Coverage for New Alzheimer's Drug
Insurance companies are weighing whether to cover Biogen’s controversial new drug for Alzheimer’s disease, which has an annual cost of $56,000.
-
FDA Sets Limits for Controversial Alzheimer Drug, Calls for Investigation
A month after approving a controversial new Alzheimer’s drug, the FDA has signed off on new prescribing instructions to limit its use to only patients with early or mild cases of the disease. The acting head of the FDA, Dr. Janet Woodcock, also announced that she was ordering an investigation into whether the agency acted improperly in approving the...
-
FDA Head Calls for Probe Into Approval of Alzheimer's Drug Aduhelm
The acting head of the Food and Drug Administration is calling for a government investigation into highly unusual contacts between her agency’s drug reviewers and the maker of a controversial new Alzheimer’s drug
-
Alzheimer's Drug Stirs Hope for Patients, Worry for Doctors
Doctors are trying to figure out who should get a new treatment for Alzheimer’s disease
-
Biogen Alzheimer's Drug and the Battle Over Dementia Treatment of the Future
Biogen Alzheimer’s drug Aduhelm is the first new treatment for dementia approved by the FDA in decades, and it’s started a war over the brain drug pipeline.
-
Here's How Insurers May Cover That Expensive New Alzheimer's Drug
Federal regulators have approved the first new drug for Alzheimer’s disease in nearly 20 years, leaving patients waiting to see how insurers will handle the pricey new treatment
-
FDA Approves Biogen's New Alzheimer's Drug
The FDA has approved a controversial drug for Alzheimer’s disease developed by Cambridge-based pharmaceutical company Biogen.